eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2011
vol. 8
 
Share:
Share:
abstract:

Evaluation of the aortic valve gradient in the patients with stentless 3F bioprothesismade of equine pericardium – one year follow-up

Krzysztof Bartuś
,
Jerzy Sadowski
,
Bogusław Kapelak
,
Jacek Myć
,
Stanisław Bartuś
,
Krzysztof Oleś
,
Grzegorz Filip

Kardiochirurgia i Torakochirurgia Polska 2011; 8 (3): 328–331
Online publish date: 2011/09/30
View full text Get citation
 
Background: The acute result of surgical replacement of aortic valve is reduction of the transvalular gradient.

The aim of the study was evaluation of the aortic valve gradient in one year follow-up (FU) of the patients with left ventricle hypertrophy after equine pericardial stentless bioprothesis replacement (3F Therapeutics, Lake Forest, USA, Medtronic, Inc., Minneapolis, USA).

Material and methods: 40 patients with left ventricle hyper­trophy [8 women and 32 men aged 23-78, mean 57 (± SD 10.2)] qualified to aortic valve replacement. Ultrasound eva­luation of the gradient was performed in 1; 3-6 and 11-14 month FU after surgery.

Results : Mean and maximal gradients were: 8.6 mmHg (± SD =

= 4.8) and 16.1 mmHg (± SD = 8.8) after procedure, after

3-6 months FU were 7.8 mmHg (± SD = 3.7) and 14.5 mmHg

(± SD = 7), 7.7 mmHg (± SD = 2.8) and 14.4 mmHg (± SD = 5.2) 11-14 months FU.

Conclusions : Mean gradient and maximal gradient were low and there were no statistically significant changes during 1-year FU in comparison to baseline values.
keywords:

stentless valves, biological valve, aortic valve, gradient

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.